Physician profile
Danny Phan
NPI 1013399211
$2,069.48
in general payments reported to CMS, 2019-2025
17 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $129 · 2021: $530 · 2022: $201 · 2023: $361 · 2024: $450 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $548.02 | 2021-2022 | |
| Treace Medical Concepts, INC. | $252.22 | 2024-2025 | |
| Medtronic, INC. | $212.66 | 2022-2024 | Intellis Adaptivestim |
| Kerecis Limited | $185.84 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Next Science LLC | $142.41 | 2024 | Blastx, Xperience, Surgx |
| Horizon Therapeutics Plc | $133.97 | 2019 | |
| Smith+Nephew, INC. | $119.14 | 2023 | Regranex |
| Urgo Medical North America, LLC | $117.94 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Stability Biologics, LLC | $107.62 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $102.91 | 2020 | |
| Organogenesis INC. | $55.20 | 2021-2022 | |
| Integra Lifesciences Corporation | $19.86 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.68 | 2023 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.92 | 2019 | |
| Amgen INC. | $13.76 | 2025 | Krystexxa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $13.56 | 2020 | |
| Misonix INC | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.